81287 Management gene prmtr mthyltn alys
Pathology & Lab
Also known as: MGMT methylation test, glioblastoma methylation status
O-6-Methylguanine-DNA Methyltransferase (MGMT) gene promoter methylation analysis to predict glioblastoma treatment response and prognosis.
Clinical Context
Detects MGMT promoter methylation in glioblastoma to predict chemotherapy response and survival. Methylated tumors show better temozolomide response.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.